Exelixis Clinical Site #160

Mexico City 06760

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Renal Cell Carcinoma

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy — Running, not enrolling
• Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma — Running, not enrolling